Alcon, the global leader in eye care and a division of Novartis (NYSE: NVS), has received European CE Mark for its AcrySof IQ Aspheric IOL with the UltraSert Pre-loaded Delivery System for patients ...
Basel, Switzerland, July 1, 2015 – Alcon, the global leader in eye care and a division of Novartis, has received European CE Mark for its AcrySof® IQ Aspheric IOL with the UltraSert™ Pre-loaded ...
Please provide your email address to receive an email when new articles are posted on . Alcon received FDA approval for its AcrySof IQ aspheric IOL with the UltraSert preloaded delivery system for ...
Alcon, the global leader in eye care and a division of Novartis (NYSE: NVS), has received US Food and Drug Administration (FDA) approval for its AcrySof IQ Aspheric IOL with the UltraSert Pre-loaded ...
FORT WORTH, Texas--(BUSINESS WIRE)--May 21, 2006--Alcon, Inc. (NYSE:ACL) announced today that the Centers for Medicare and Medicaid Services (CMS) recognized the AcrySof(R) IQ intraocular lens (IOL) ...
Basel, July 1, 2015-Alcon, the global leader in eye care and a division of Novartis, has received European CE Mark for its AcrySof® IQ Aspheric IOL with the UltraSertTM Pre-loaded Delivery System for ...
Basel, October 5, 2015-Alcon, the global leader in eye care and a division of Novartis, has received US Food and Drug Administration (FDA) approval for its AcrySof® IQ Aspheric IOL with the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results